X-85864663-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_000390.4(CHM):āc.1929A>Cā(p.Thr643=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,208,528 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 43 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.00012 ( 0 hom. 43 hem. )
Consequence
CHM
NM_000390.4 synonymous
NM_000390.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.81
Genes affected
CHM (HGNC:1940): (CHM Rab escort protein) This gene encodes component A of the RAB geranylgeranyl transferase holoenzyme. In the dimeric holoenzyme, this subunit binds unprenylated Rab GTPases and then presents them to the catalytic Rab GGTase subunit for the geranylgeranyl transfer reaction. Rab GTPases need to be geranylgeranyled on either one or two cysteine residues in their C-terminus to localize to the correct intracellular membrane. Mutations in this gene are a cause of choroideremia; also known as tapetochoroidal dystrophy (TCD). This X-linked disease is characterized by progressive dystrophy of the choroid, retinal pigment epithelium and retina. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant X-85864663-T-G is Benign according to our data. Variant chrX-85864663-T-G is described in ClinVar as [Benign]. Clinvar id is 1165534.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.81 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 43 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHM | NM_000390.4 | c.1929A>C | p.Thr643= | synonymous_variant | 15/15 | ENST00000357749.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHM | ENST00000357749.7 | c.1929A>C | p.Thr643= | synonymous_variant | 15/15 | 1 | NM_000390.4 | P1 | |
CHM | ENST00000467744.2 | n.127-1569A>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000895 AC: 1AN: 111678Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33842
GnomAD3 genomes
AF:
AC:
1
AN:
111678
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33842
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000167 AC: 3AN: 179657Hom.: 0 AF XY: 0.0000310 AC XY: 2AN XY: 64617
GnomAD3 exomes
AF:
AC:
3
AN:
179657
Hom.:
AF XY:
AC XY:
2
AN XY:
64617
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000118 AC: 129AN: 1096850Hom.: 0 Cov.: 29 AF XY: 0.000119 AC XY: 43AN XY: 362384
GnomAD4 exome
AF:
AC:
129
AN:
1096850
Hom.:
Cov.:
29
AF XY:
AC XY:
43
AN XY:
362384
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000895 AC: 1AN: 111678Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33842
GnomAD4 genome
AF:
AC:
1
AN:
111678
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33842
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Choroideremia Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 11, 2020 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 17, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at